Kilitch Drugs (India) Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: KILITCH BSE: 524500

₹233.74

Oct. 5, 2026 · NSE · nse_bhavcopy

Peers in Pharmaceuticals & Biotechnology

The largest companies in the same industry by market cap. This company ranks #95 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

Company	Market cap (₹ Cr)	PE (TTM)	ROE	1Y return	Div. yield	Quality	Valuation	Momentum
Sun Pharmaceutical Industries Limited	427,010	143.5	13.7%	7.6%	—	72	8	30
Divi's Laboratories Limited	244,125	83.0	15.3%	57.8%	0.33%	70	4	51
Torrent Pharmaceuticals Limited	161,506	77.7	12.2%	35.3%	0.80%	56	0	31
Zydus Lifesciences Limited	113,616	32.6	17.3%	14.5%	0.09%	74	24	84
Cipla Limited	107,888	35.1	11.2%	-11.7%	0.97%	73	29	62
Laurus Labs Limited	106,505	122.0	17.1%	128.4%	—	78	24	53
Mankind Pharma Limited	102,382	46.9	11.7%	0.9%	—	68	12	86
Dr. Reddy's Laboratories Limited	100,411	150.9	10.9%	-3.7%	—	62	33	71
Kilitch Drugs (India) Limited (this stock)	817	17.3	10.7%	-37.2%	—	82	72	72

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value

₹896 Cr

EV / EBITDA

18.9x

EV / Sales

4.59x

Market cap / Sales

4.18x

Earnings yield

5.79%

Quarterly Financials

Download CSV

Standalone Consolidated

↑ Positive

Quarterly Revenue

Jun 2026 quarterly revenue is Rs 44 Cr, up 18.2% YoY.

Period end	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)	Basic EPS
June 30, 2026	41	7	5	₹1.4500
March 31, 2026	72	19	14	₹4.0800
Dec. 31, 2025	45	6	5	₹2.7400
Sept. 30, 2025	38	10	9	₹5.2700
June 30, 2025	34	6	5	₹2.9800
March 31, 2025	56	15	11	₹
Dec. 31, 2024	47	10	7	₹4.2800
Sept. 30, 2024	45	11	9	₹5.5000
June 30, 2024	33	6	4	₹2.5200
March 31, 2024	39	5	4	₹2.2600
Dec. 31, 2023	30	7	5	₹3.4800
Sept. 30, 2023	32	6	4	₹2.6000
June 30, 2023	31	6	4	₹2.6900

Quarterly income statement (standalone, ₹ Cr)

Indicator	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23
Total income (before exceptional items)	44	73	46	45	38	49	51	37	40	33	32	32	45
Operating revenue	41	72	45	38	34	47	45	33	39	30	32	31	43
Other income	4	1	2	8	3	2	6	3	1	3	1	1	1
Operating expenses	36	52	39	34	31	38	40	30	34	26	26	26	37
Operating profit	5	19	6	4	4	8	6	3	5	4	6	5	7
Operating profit margin	11.4%	27.1%	12.8%	9.7%	10.5%	17.5%	12.3%	9.6%	13.3%	13.5%	18.1%	16.8%	15.5%
Depreciation	1	1	1	1	0	0	0	0	0	0	0	0	0
Interest	0	1	1	1	1	0	0	0	0	1	0	0	0
Exceptional items, gain / (loss)	—	—	—	—	—	—	—	—	—	—	—	—	—
Profit before tax	7	19	6	10	6	10	11	6	5	7	6	6	7
Tax	2	5	1	1	1	3	2	2	2	1	2	1	2
Net profit	—	14	—	9	5	7	9	4	4	6	4	4	5
EPS	1.45	4.08	2.74	5.27	2.98	4.28	5.50	2.52	2.26	3.48	2.60	2.69	3.29
Net profit (TTM)	—	—	—	29	25	23	22	17	18	19	17	17	16
EPS (TTM)	13.54	15.07	15.27	18.03	15.28	14.56	13.76	10.86	11.03	12.06	11.11	10.85	10.09

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Year ended	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)
March 31, 2026	189	42	32
March 31, 2025	182	41	31
March 31, 2024	132	23	18
March 31, 2023	118	19	16

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

Indicator	CAGR 3Y	CAGR 5Y	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Total income (before exceptional items)	18.3%	22.2%	202^†	—	138^†	122^†	110^†	74^†	66^†	101^†	53^†	29^†
Operating revenue	17.0%	21.9%	189	182	132	118	105^†	70^†	61^†	96^†	50^†	28^†
Other income	—	—	14^†	—	6^†	5^†	5^†	4^†	6^†	5^†	3^†	1^†
Operating expenses	—	—	156^†	—	111^†	101^†	94^†	65^†	59^†	—	—	—
Operating profit	23.6%	44.2%	32^†	—	20^†	17^†	11^†	5^†	1^†	—	—	—
Operating profit margin	—	—	17.2%^†	—	15.3%^†	14.6%^†	10.5%^†	7.4%^†	2.3%^†	—	—	—
Depreciation	—	—	2^†	—	1^†	1^†	1^†	1^†	1^†	1^†	1^†	1^†
Interest	—	—	2^†	—	2^†	1^†	1^†	1^†	1^†	—	—	—
Exceptional items, gain / (loss)	—	—	0^†	—	0^†	0^†	0^†	0^†	0^†	0^†	0^†	0^†
Profit before tax	28.8%	40.8%	42	41	23	19	14^†	8^†	5^†	20^†	7^†	-3^†
Tax	—	—	9^†	—	6^†	4^†	3^†	1^†	1^†	5^†	1^†	-1^†
Net profit	27.3%	39.4%	32	31	18	16	11^†	6^†	4^†	15^†	6^†	-2^†
EPS	14.3%	30.5%	15.07^†	—	11.03^†	10.09^†	6.76^†	3.98^†	2.89^†	—	—	—

^† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

Ratio	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Operating margin	17.2%^†	—	15.3%^†	14.6%^†	10.5%^†	7.4%^†	2.3%^†	—	—	—
EBIT margin	23.3%^†	—	19.1%^†	17.3%^†	13.9%^†	11.8%^†	9.8%^†	—	—	—
PBT margin	22.0%	22.4%	17.7%	16.5%	13.2%^†	10.7%^†	8.6%^†	20.3%^†	14.2%^†	-9.1%^†
Net margin	17.2%	17.2%	13.4%	13.3%	10.0%^†	8.8%^†	7.3%^†	15.3%^†	12.3%^†	-7.1%^†
Interest coverage	18.01x^†	—	14.10x^†	20.74x^†	22.02x^†	10.95x^†	8.29x^†	—	—	—
Dividend payout	0.0%^†	—	0.0%^†	0.0%^†	0.0%^†	0.0%^†	17.3%^†	—	—	—
Earnings retention	100.0%^†	—	100.0%^†	100.0%^†	100.0%^†	100.0%^†	82.7%^†	—	—	—
Current ratio	1.92x	2.10x	—	—	—	—	—	—	—	—
Quick ratio	1.82x	1.91x	—	—	—	—	—	—	—	—
Debt to equity	0.27x	0.19x	—	—	—	—	—	—	—	—
Return on equity	9.7%	12.3%	—	—	—	—	—	—	—	—
Return on assets	6.5%	8.7%	—	—	—	—	—	—	—	—
Return on capital employed	11.2%^†	—	—	—	—	—	—	—	—	—
Asset turnover	0.38x	0.51x	—	—	—	—	—	—	—	—

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year ended	Operating (₹ Cr)	Investing (₹ Cr)	Financing (₹ Cr)	Capex (₹ Cr)	Free Cash Flow (₹ Cr)
March 31, 2026	12	-96	86	95	-83
March 31, 2025	15	-41	16	47	-32
March 31, 2024	-1	-10	11	7	-8
March 31, 2023	6	6	3	4	3
March 31, 2022	5	-16	8	8	-3

Balance Sheet (standalone)

Year ended	Total Assets (₹ Cr)	Total Equity (₹ Cr)	Reserves (₹ Cr)	Borrowings, Current (₹ Cr)	Borrowings, Non-current (₹ Cr)	Current Assets (₹ Cr)	Current Liabilities (₹ Cr)	Cash & Equivalents (₹ Cr)	Net Block (₹ Cr)	Inventory (₹ Cr)
March 31, 2026	499	333	298	30	59	206	107	9	19	12
March 31, 2025	358	253	237	21	28	162	77	7	19	15
March 31, 2024	—	—	—	—	—	—	—	—	—	—
March 31, 2023	—	—	—	—	—	—	—	—	—	—
March 31, 2022	—	—	—	—	—	—	—	—	—	—

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.